See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411685_2021_Vistagen_Therapeutics_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.6843955284084361, 'aggregate_val': 11501700, 'exp_sum': 36443400, 'exp_to_value': {'LiabilitiesCurrent': 27713000, 'LiabilitiesNoncurrent': 8730400, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001411685, Vistagen Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,580,200 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 209,600 |
| 3 | remainder_Assets | 3,982,500 |
| 4 | LiabilitiesCurrent | 27,713,000 |
| 5 | LiabilitiesNoncurrent | 8,730,400 |
| 6 | remainder_Liabilities | -24,941,700 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,426,523 |
| 9 | ResearchAndDevelopmentExpense | 13,297,582 |
| 10 | remainder_Expenses | 2,600 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 17,310 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,772,300 |
| 1 | Liabilities | 11,501,700 |
| 2 | Expenses | 20,726,705 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -5,729,400 |
| 5 | NetIncome | -20,709,395 |
| 6 | ComprehensiveNetIncome | -20,709,395 |
| 7 | BaseVar | 19,009,008 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.84 |
| 9 | EconomicCapitalRatio | 0.433 |
Edgar->Model Mapping
Feature Distribution
Change over Time
